Page results
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
File results
-
FOI/2024/0607 - Starvation ketoacidosis patients/ treatment
-
FOI/2024/0609 - Healthcare Associated Infections (HAIs) cases
-
FOI/2024/0615 - Electronic Patient Record (EPR) software spend/ Trust Integration Engine (TIE)
-
FOI/2024/0612 - Orthotic and prosthetic services at the Trust
-
FOI/2024/0616 - Never events involving Medical Associate Professionals (MAPs) from 2021/22-2023/24
-
FOI/2024/0617 - Vascular access devices purchased - Peripherally Inserted Central Catheters (PICC)/ Midline Catheters
-
FOI/2024/0622 - Guidelines and policies for the treatment of Dravet and Lennox-Gastaut syndrome
-
FOI/2024/0623 - Patient numbers sent to use MRI scanner at London Zoo from 2014-2024
-
FOI/2024/0626 - Number of patients with Waldenström Macroglobulinemia and treatments
-
FOI/2024/0627 - E-signature vendor supplier and cost